Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
Rapharma expands its immunosuppressants portfolio
Rapharma is releasing Landotex® (INN lenalidomide) in Russia. Landotex® is a Russian generic of lenalidomide that is not inferior in quality to the original drug but is less expensive. The drug is included in the Russian Federation's 14 Cost-Intensive Nosologies state programme, and its procurement is coordinated accordingly.
The drug is prescribed to adults who have multiple myeloma, myelodysplastic syndromes, follicular lymphoma, or lymphoma of the mantle zone or basal border.
Rapharma that places a high value on the quality of its products, has its own pharmaceutical complex that was designed and built in accordance with EU GMP requirements.
Rapharma works to increase the availability of medicines for patients of all income levels as part of its proactive support for the development of Russian healthcare.